1152 related articles for article (PubMed ID: 22336189)
1. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.
Makkar RR; Smith RR; Cheng K; Malliaras K; Thomson LE; Berman D; Czer LS; Marbán L; Mendizabal A; Johnston PV; Russell SD; Schuleri KH; Lardo AC; Gerstenblith G; Marbán E
Lancet; 2012 Mar; 379(9819):895-904. PubMed ID: 22336189
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).
Malliaras K; Makkar RR; Smith RR; Cheng K; Wu E; Bonow RO; Marbán L; Mendizabal A; Cingolani E; Johnston PV; Gerstenblith G; Schuleri KH; Lardo AC; Marbán E
J Am Coll Cardiol; 2014 Jan; 63(2):110-22. PubMed ID: 24036024
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
Makkar RR; Kereiakes DJ; Aguirre F; Kowalchuk G; Chakravarty T; Malliaras K; Francis GS; Povsic TJ; Schatz R; Traverse JH; Pogoda JM; Smith RR; Marbán L; Ascheim DD; Ostovaneh MR; Lima JAC; DeMaria A; Marbán E; Henry TD
Eur Heart J; 2020 Sep; 41(36):3451-3458. PubMed ID: 32749459
[TBL] [Abstract][Full Text] [Related]
4. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction.
Malliaras K; Smith RR; Kanazawa H; Yee K; Seinfeld J; Tseliou E; Dawkins JF; Kreke M; Cheng K; Luthringer D; Ho CS; Blusztajn A; Valle I; Chowdhury S; Makkar RR; Dharmakumar R; Li D; Marbán L; Marbán E
Circulation; 2013 Dec; 128(25):2764-75. PubMed ID: 24061088
[TBL] [Abstract][Full Text] [Related]
5. Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial.
Ostovaneh MR; Makkar RR; Ambale-Venkatesh B; Ascheim D; Chakravarty T; Henry TD; Kowalchuk G; Aguirre FV; Kereiakes DJ; Povsic TJ; Schatz R; Traverse JH; Pogoda J; Smith RD; Marbán L; Marbán E; Lima JAC
Open Heart; 2021 Jul; 8(2):. PubMed ID: 34233913
[TBL] [Abstract][Full Text] [Related]
6. Nonocclusive multivessel intracoronary infusion of allogeneic cardiosphere-derived cells early after reperfusion prevents remote zone myocyte loss and improves global left ventricular function in swine with myocardial infarction.
Suzuki G; Weil BR; Young RF; Fallavollita JA; Canty JM
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H345-H356. PubMed ID: 31125261
[TBL] [Abstract][Full Text] [Related]
7. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
Bolli R; Chugh AR; D'Amario D; Loughran JH; Stoddard MF; Ikram S; Beache GM; Wagner SG; Leri A; Hosoda T; Sanada F; Elmore JB; Goichberg P; Cappetta D; Solankhi NK; Fahsah I; Rokosh DG; Slaughter MS; Kajstura J; Anversa P
Lancet; 2011 Nov; 378(9806):1847-57. PubMed ID: 22088800
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
11. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
[TBL] [Abstract][Full Text] [Related]
12. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair.
Cheng K; Malliaras K; Smith RR; Shen D; Sun B; Blusztajn A; Xie Y; Ibrahim A; Aminzadeh MA; Liu W; Li TS; De Robertis MA; Marbán L; Czer LSC; Trento A; Marbán E
JACC Heart Fail; 2014 Feb; 2(1):49-61. PubMed ID: 24511463
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction.
Gallet R; Tseliou E; Dawkins J; Middleton R; Valle J; Angert D; Reich H; Luthringer D; Kreke M; Smith R; Marbán L; Marbán E
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25953823
[TBL] [Abstract][Full Text] [Related]
14. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy.
Johnston PV; Sasano T; Mills K; Evers R; Lee ST; Smith RR; Lardo AC; Lai S; Steenbergen C; Gerstenblith G; Lange R; Marbán E
Circulation; 2009 Sep; 120(12):1075-83, 7 p following 1083. PubMed ID: 19738142
[TBL] [Abstract][Full Text] [Related]
15. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.
Smith RR; Barile L; Cho HC; Leppo MK; Hare JM; Messina E; Giacomello A; Abraham MR; Marbán E
Circulation; 2007 Feb; 115(7):896-908. PubMed ID: 17283259
[TBL] [Abstract][Full Text] [Related]
16. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
Chakravarty T; Makkar RR; Ascheim DD; Traverse JH; Schatz R; DeMaria A; Francis GS; Povsic TJ; Smith RR; Lima JA; Pogoda JM; Marbán L; Henry TD
Cell Transplant; 2017 Feb; 26(2):205-214. PubMed ID: 27543900
[TBL] [Abstract][Full Text] [Related]
17. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Assmus B; Schächinger V; Teupe C; Britten M; Lehmann R; Döbert N; Grünwald F; Aicher A; Urbich C; Martin H; Hoelzer D; Dimmeler S; Zeiher AM
Circulation; 2002 Dec; 106(24):3009-17. PubMed ID: 12473544
[TBL] [Abstract][Full Text] [Related]
20. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
